James R. Berenson, MD . President and CEO - James R. Berenson, MD, Inc. Medical & Scientific Director - Institute for Myeloma & Bone Cancer Research (IMBCR) Chief Executive Officer - Oncotherapeutics. Multiple myeloma (active) is the most common type plasma cell cancer. However, the following are other forms of myeloma or myeloma-related ....